
TY  - JOUR
TI  - 47th Annual Meeting of the German Society for Immunology, 12–15 September, 2017, Erlangen, Germany
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 47
IS  - S2
SN  - 0014-2980
UR  - https://doi.org/10.1002/eji.201770300
DO  - doi:10.1002/eji.201770300
SP  - 1
EP  - 333
PY  - 2017
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Immunology
JA  - Immunology
VL  - 140
IS  - s1
SN  - 0019-2805
UR  - https://doi.org/10.1111/imm.12184
DO  - doi:10.1111/imm.12184
SP  - 39
EP  - 184
PY  - 2013
ER  - 

TY  - JOUR
AU  - Nielsen, Susanne Schouw
AU  - Grøfte, Thorbjørn
AU  - Tygstrup, Niels
AU  - Vilstrup, Hendrik
TI  - Effect of lipopolysaccharide on in vivo and genetic regulation of rat urea synthesis
JO  - Liver International
VL  - 25
IS  - 1
SN  - 1478-3223
UR  - https://doi.org/10.1111/j.1478-3231.2005.01039.x
DO  - doi:10.1111/j.1478-3231.2005.01039.x
SP  - 177
EP  - 183
KW  - acute phase response
KW  - hepatic amino nitrogen conversion
KW  - messenger ribonucleic acid
PY  - 2005
AB  - Abstract: Background: The acute phase response causes a negative nitrogen balance. It is unknown whether this involves regulation of hepatic urea synthesis. Methods: We examined the in vivo capacity of urea nitrogen synthesis (CUNS), mRNA levels of urea cycle enzyme genes and galactose elimination capacity (GEC) during moderate and severe acute phase response induced by low- and high-dose lipopolysaccharide (LPS) in rats. Results: Low-dose LPS doubled CUNS (P<0.05), decreased the mRNA level of the rate-limiting urea cycle enzyme (arginino succinate synthetase (ASS) by 26% (P<0.05) and did not change GEC. High-dose LPS did not change CUNS, decreased the mRNA level of the flux-generating enzyme carbamoyl phosphate synthetase (CPS) by 11% (P<0.05) and the rate-limiting urea cycle enzyme (ASS) by 27% (P<0.05) and almost halved GEC (P<0.05). Conclusion: The moderate acute phase response up-regulated in vivo urea synthesis but had the opposite effect on gene level. The severe acute phase response decreased the functional liver mass that attenuated the increase in urea synthesis.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Immunology
VL  - 125
IS  - s1
SN  - 0019-2805
UR  - https://doi.org/10.1111/j.1365-2567.2008.02974.x
DO  - doi:10.1111/j.1365-2567.2008.02974.x
SP  - 1
EP  - 144
PY  - 2008
ER  - 

TY  - JOUR
TI  - TSANZ Oral Abstracts
JO  - Respirology
VL  - 17
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2012.02142.x
DO  - doi:10.1111/j.1440-1843.2012.02142.x
SP  - 12
EP  - 41
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Neurochemistry
VL  - 99
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.0022-3042.2006.04234.x
DO  - doi:10.1111/j.0022-3042.2006.04234.x
SP  - 1
EP  - 35
PY  - 2006
ER  - 

TY  - JOUR
TI  - 5th World Congress of the International Academy of Oral Oncology (IAOO)
JO  - Head & Neck
JA  - Head Neck
VL  - 37
IS  - S1
SN  - 1043-3074
UR  - https://doi.org/10.1002/hed.24138
DO  - doi:10.1002/hed.24138
SP  - E1
EP  - E227
PY  - 2015
ER  - 

TY  - JOUR
TI  - Winter Meeting 2012. 201st Scientific Meeting of the Pathological Society of Great Britain & Ireland, 5–6 January
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 226
IS  - S1
SN  - 0022-3417
UR  - https://doi.org/10.1002/path.4005
DO  - doi:10.1002/path.4005
SP  - S1
EP  - S34
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Fundamental & Clinical Pharmacology
VL  - 21
IS  - s1
SN  - 0767-3981
UR  - https://doi.org/10.1111/j.1472-8206.2007.00481.x
DO  - doi:10.1111/j.1472-8206.2007.00481.x
SP  - 1
EP  - 99
PY  - 2007
ER  - 

TY  - JOUR
TI  - SSIEM 2015 Annual Symposium
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 38
IS  - S1
SN  - 0141-8955
UR  - https://doi.org/10.1007/s10545-015-9877-x
DO  - doi:10.1007/s10545-015-9877-x
SP  - 35
EP  - 378
PY  - 2015
ER  - 

TY  - JOUR
TI  - Proceedings of the 17th Annual Congress of the European Society for Sexual Medicine, Copenhagen, Denmark, February 5–7, 2015
JO  - The Journal of Sexual Medicine
JA  - J Sex Med
VL  - 12
IS  - S3
SN  - 1743-6095
UR  - https://doi.org/10.1111/jsm.12872_2
DO  - doi:10.1111/jsm.12872_2
SP  - 188
EP  - 271
PY  - 2015
ER  - 

AU  - Freeland-Graves, Jeanne H.
AU  - Bose, Tanushree
AU  - Karbassian, Abbass
C7  - pp. 159-178
TI  - 25Mn Manganese Metallotherapeutics
SN  - 9780470864036
UR  - https://doi.org/10.1002/0470864052.ch9
DO  - doi:10.1002/0470864052.ch9
SP  - 159-178
KW  - Manganese (Mn)
KW  - manganese ethylene-bis-dithiocarbamate
KW  - manganese superoxide dismutase (SOD)
KW  - manganese neurotoxicity
KW  - Parkinson-like syndrome
KW  - manganese-rich herbs and manganese salts
KW  - SOD mimetics (SODm)
KW  - osteoporosis
KW  - SOD gene variations
PY  - 2015
AB  - Summary This chapter contains sections titled: Prevalence in the Environment Diet and Water Functions MnSOD Deficiency Toxicity Therapeutic Manganese-Related Agents Therapeutic Uses Magnetic Resonance Imaging (MRI) Future Implications Acknowledgements References
ER  - 

TY  - JOUR
C7  - e13384
TI  - Poster Session A
JO  - Acta Physiologica
JA  - Acta Physiol
VL  - 227
IS  - S719
SN  - 9780470864036
UR  - https://doi.org/10.1111/apha.13384
DO  - doi:10.1111/apha.13384
SP  - e13384
PY  - 2019
ER  - 

TY  - JOUR
TI  - II Joint Meeting of the German Society for Immunology (DGfl) and the Italian Society of Immunology, Clinical Immunology and Allergology (SIICA), 10–13 September, 2019, Munich, Germany
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 49
IS  - S1
SN  - 9780470864036
UR  - https://doi.org/10.1002/eji.201970300
DO  - doi:10.1002/eji.201970300
SP  - 1
EP  - 306
PY  - 2019
ER  - 

AU  - Gensel, John C.
C7  - pp. 339-361
TI  - Spinal Cord Injury
SN  - 9781118406410
UR  - https://doi.org/10.1002/9781118406557.ch14
DO  - doi:10.1002/9781118406557.ch14
SP  - 339-361
KW  - spinal cord injury
KW  - macrophage
KW  - microglia
KW  - astrocyte
KW  - neutrophil
KW  - B cell
KW  - T cell
KW  - neuroinflammation
KW  - clinical trial
KW  - therapy
PY  - 2019
AB  - Summary Traumatic spinal cord injury (SCI) triggers a robust inflammatory response consisting of activated neutrophils, macrophages, astrocytes, T cells and B cells. The magnitude and timing of the immune response vary depending upon the spinal level of injury (thoracic vs. cervical), injury severity, species and strain, age at the time of injury, and mode of injury (i.e. contusion, compression or ischemic). Regardless of these factors, however, these immune responses persist after SCI and contribute to pathological and reparative processes. Throughout this chapter, we will discuss the role that individual aspects of the innate and adaptive immune responses may be playing in repair or pathology after SCI. Where appropriate, current clinical therapies targeting these immune response will be highlighted.
ER  - 

TY  - JOUR
AU  - Pierre, Joseph F.
AU  - Heneghan, Aaron F.
AU  - Lawson, Christy M.
AU  - Wischmeyer, Paul E.
AU  - Kozar, Rosemary A.
AU  - Kudsk, Kenneth A.
TI  - Pharmaconutrition Review
JO  - Journal of Parenteral and Enteral Nutrition
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 37
IS  - 5S
SN  - 9781118406410
UR  - https://doi.org/10.1177/0148607113493326
DO  - doi:10.1177/0148607113493326
SP  - 51S
EP  - 65S
KW  - immunonutrition
KW  - pharmaconutrition
KW  - immune modulation
KW  - nutrition therapy
PY  - 2013
AB  - The search to improve outcomes in critically ill patients through nutrition support has steadily progressed over the past 4 decades. One current approach to this problem is the addition of specific nutrients as primary therapy to improve host defenses and improve the outcome of critically ill patients. The field is referred to as ?pharmaconutrition,? with the hope of focusing investigations on each nutrient to understand its pharmacological effects on immune and clinical outcomes. The purpose of this review is to describe some of the known physiological mechanisms of pharmaconutrients such as glutamine, arginine, ?-3 fatty acids, and selenium.
ER  - 

TY  - JOUR
TI  - Oral Presentations
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 41
IS  - S1
SN  - 9781118406410
UR  - https://doi.org/10.1007/s10545-018-0233-9
DO  - doi:10.1007/s10545-018-0233-9
SP  - 37
EP  - 219
PY  - 2018
ER  - 

TY  - JOUR
TI  - GLIA Edinburgh 2017: Abstracts Oral Presentations, Posters, Indexes
JO  - Glia
JA  - Glia
VL  - 65
IS  - S1
SN  - 9781118406410
UR  - https://doi.org/10.1002/glia.23157
DO  - doi:10.1002/glia.23157
SP  - E103
EP  - E578
PY  - 2017
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Immunology
JA  - Immunology
VL  - 143
IS  - s2
SN  - 9781118406410
UR  - https://doi.org/10.1111/imm.12406
DO  - doi:10.1111/imm.12406
SP  - 62
EP  - 176
PY  - 2014
ER  - 

TY  - JOUR
AU  - Ochoa, Juan B.
AU  - Strange, Jennifer
AU  - Kearney, Paul
AU  - Gellin, Gloria
AU  - Endean, Eric
AU  - Fitzpatrick, Elizabeth
TI  - Effects of L-Arginine on the Proliferation of T Lymphocyte Subpopulations
JO  - Journal of Parenteral and Enteral Nutrition
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 25
IS  - 1
SN  - 9781118406410
UR  - https://doi.org/10.1177/014860710102500123
DO  - doi:10.1177/014860710102500123
SP  - 23
EP  - 29
PY  - 2001
AB  - Background: Dietary supplementation of L-arginine as a mechanism to enhance cellular immune response (T lymphocytes), has slowly gained approval, and appears especially important during critical illness. Despite its clinical use, little is known as to the direct effects of L-arginine on the different T lymphocyte subpopulations. Methods: Lymphocytes were harvested from spleens of C57 Bl/6 mice, and proliferation was induced with anti-CD3 in the presence of different concentrations of L-arginine ranging from 0 to 1000 ?mol/L. Flow cytometry was used to evaluate the effect of L-arginine on T lymphocyte subpopulations. Interleukin-2 production was measured by ELISA and gene expression by RT-PCR. Results: L-Arginine at or greater than 100 ?mol/L significantly enhanced anti-CD3 stimulated T lymphocyte proliferation (p =.01). L-Arginine was essential for adequate T lymphocyte (CD3+) cellular maturation (p =.01). Proliferation of Helper T cells (CD4+) was not dependent on L-arginine. In contrast, Cytotoxic T cells (CD8+) showed a dose dependent proliferation in response to L-arginine (p =.01). Of the CD8+ cells, an increase in the CD45RA negative CD8 positive (memory) T cell subpopulation was observed with the addition of L-arginine. In addition, the number of cell surface CD8 receptors (CD8R) and CD3 receptors (CD3R) increased in the presence of L-arginine (p =.01, p =.04). Interleukin-2 receptor (IL-2R) expression was not up-regulated by L-arginine. L-Arginine modestly increased IL-2 production and had pronounced effects on its disappearance from the culture media (p <.0001). Interleukin-2 mRNA expression was not dependent on L-arginine. Conclusions: The requirements for L-arginine for the proliferation of CD3 stimulated T lymphocytes vary widely, and have to be taken into account when studying the mechanism of how L-arginine enhances cellular proliferation. L-Arginine may increase cellular proliferation by increasing specific receptor expression and the utilization of interleukin-2. (Journal of Parenteral and Enteral Nutrition 25:23?29, 2001)
ER  - 
